MIS (minimally invasive surgery) may be the answer to waiting list problem
This article was originally published in Clinica
The UK's newly re-elected Labour government has a huge challenge if it hopes to meet its promise to reduce waiting times for medical treatment. One of the tools that it hopes will help to achieve its goal is minimally invasive surgery (MIS). But, as delegates heard at the recent conference in London on MIS, the uptake is slow.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.